CommercialCoverageHigh impact
Cold Laser and High-Power Laser Therapies (CPB 0363, reviewed 2026-07-15)
Aetna·Oncology, Radiation Oncology, Dentistry +7 more·Medical Policy
Effective date
Jul 15, 2026
We identified it
Aug 15, 2026
Summary
Aetna's updated Clinical Policy Bulletin (CPB 0363) effective 2026-07-15 narrows coverage for laser therapies: ONLY low-level laser therapy for oral mucositis prevention during cancer treatment is medically necessary and covered. All other laser therapy indications (including carpal tunnel, back pain, arthritis, wound healing, etc.) are classified as experimental/investigational and NOT covered. Billing teams must immediately identify and deny claims for non-covered laser codes when billed for excluded diagnoses.
Action Required
IMMEDIATE - Before 2026-07-15: (1) Billing team must update claim adjudication system to deny CPT 0552T, 1011T, 97037 and HCPCS S8948 when submitted with ANY ICD-10 diagnosis EXCEPT K12.30-K12.39 (oral mucositis). (2) Create system hard-stop rule: If laser therapy code is billed with diagnoses such as G56.00 (carpal tunnel), M79.7 (fibromyalgia), L64 (alopecia), S76 (hamstring injury), M77.9 (tendinopathy), I89.0 (lymphedema), or ANY of the 50+ listed experimental indications, automatically deny with message 'Experimental/Investigational per CPB 0363.' (3) Billing team and coders must flag all pending claims using these codes for diagnosis review; recoup any paid claims for non-covered indications. (4) Notify all in-network providers and facilities performing laser therapy of coverage restriction via bulletin. (5) Update patient financial counseling: warn patients before laser therapy that non-mucositis treatments will not be covered. Failure to implement will result in significant claim denials and potential overpayment recovery.